Invention Grant
- Patent Title: Quinuclidine derivatives binding to mucarinic M3 receptors
- Patent Title (中): 奎宁环衍生物与粘蛋白M3受体结合
-
Application No.: US12582291Application Date: 2009-10-20
-
Publication No.: US08168654B2Publication Date: 2012-05-01
- Inventor: Stephen P Collingwood , Brian Cox , Urs Baettig , Gurdip Bhalay , Nicholas J Devereux
- Applicant: Stephen P Collingwood , Brian Cox , Urs Baettig , Gurdip Bhalay , Nicholas J Devereux
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Cozette M McAvoy
- Priority: GB0310232.4 20030502; GB0324887.9 20031024
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/44 ; C07D453/02 ; C07D241/02
Abstract:
Compounds of formula I in salt or zwitterionic form wherein, wherein R1, R2, R3, and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Public/Granted literature
- US20100041887A1 QUINUCLIDINE DERIVATIVES BINDING TO MUCARINIC M3 RECEPTORS Public/Granted day:2010-02-18
Information query
IPC分类:
